posted on 2019-02-11, 00:00authored byColine Canovas, Mathieu Moreau, Jean-Marc Vrigneaud, Pierre-Simon Bellaye, Bertrand Collin, Franck Denat, Victor Goncalves
The
combination of two imaging probes on the same biomolecule gives
access to targeted bimodal imaging agents that can provide more accurate
diagnosis, complementary information, or that may be used in different
applications, such as nuclear imaging and fluorescence guided surgery.
In this study, we demonstrate that dichlorotetrazine, a small, commercially
available compound, can be used as a modular platform to easily assemble
various imaging probes. Doubly labeled tetrazines can then be conjugated
to a protein through a biorthogonal IEDDA reaction. A series of difunctionalized
tetrazine compounds containing various chelating agents and fluorescent
dyes was synthesized. As a proof of concept, one of these bimodal
probes was conjugated to trastuzumab, previously modified with a constrained
alkyne group, and the resulting dual-labeled antibody was evaluated
in a mouse model, bearing a HER2-positive tumor. A significant uptake
into tumor tissues was observed in vivo, by both SPECT-CT and
fluorescence imaging, and confirmed ex vivo in biodistribution studies.